97 related articles for article (PubMed ID: 6812543)
1. Immunity to Pseudomonas keratitis in rabbits vaccinated with extracellular slime from mucoid Pseudomonas aeruginosa strains producing proteases.
Maresz-Babczyszyn J; Sokalska M
Arch Immunol Ther Exp (Warsz); 1981; 29(5):653-6. PubMed ID: 6812543
[No Abstract] [Full Text] [Related]
2. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases.
Kreger AS; Lyerly DM; Hazlett LD; Berk RS
Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):932-9. PubMed ID: 3519522
[TBL] [Abstract][Full Text] [Related]
3. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
Sokalska M; Maresz-Babczyszyn J
Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity.
Thibodeaux BA; Caballero AR; Dajcs JJ; Marquart ME; Engel LS; O'Callaghan RJ
Ocul Immunol Inflamm; 2005; 13(2-3):169-82. PubMed ID: 16019676
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study on the immunotherapy for the Pseudomonas keratitis in rabbits (author's transl)].
Tanaka N; Ohzeki T; Tanaka I; Kinoshita N
Nippon Ganka Gakkai Zasshi; 1977 Sep; 81(9):1252-9. PubMed ID: 415535
[No Abstract] [Full Text] [Related]
6. [Protective action of various antibody preparations in experimental bacterial sepsis].
Trautmann M; Brückner O; Hofstaetter T; Seiler FR; Hahn H
Beitr Infusionther Klin Ernahr; 1982; 9():155-65. PubMed ID: 6816213
[No Abstract] [Full Text] [Related]
7. [Effects of an antiserum prepared against purified protease of pseudomonas aeruginosa (authors transl)].
Sezen IY; Scharmann W; Blobel H
Zentralbl Bakteriol Orig A; 1975; 231(1-3):126-32. PubMed ID: 808047
[TBL] [Abstract][Full Text] [Related]
8. Some biological and immunological properties of extracellular slime from Pseudomonas aeruginosa.
Maresz-Babczyszyn J; Sokalska M
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):255-60. PubMed ID: 107919
[TBL] [Abstract][Full Text] [Related]
9. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
[TBL] [Abstract][Full Text] [Related]
10. Immunological study of glycolipoprotein isolated from extracellular slime of different Pseudomonas aeruginosa serogroups.
Stanislavsky ES; Kholodkova EV; Youshkova NA; Yourokova IB; Zhvanetskaya MI
Acta Microbiol Hung; 1986; 33(1):55-67. PubMed ID: 3092559
[TBL] [Abstract][Full Text] [Related]
11. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA
Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
13. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
Pier G
Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
[TBL] [Abstract][Full Text] [Related]
14. Degradation of uniquely glycosylated secretory immunoglobulin a in tears from patients with Pseudomonas aeruginosa keratitis.
Lomholt JA; Kilian M
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4939-44. PubMed ID: 18757515
[TBL] [Abstract][Full Text] [Related]
15. Role of innate and adaptive immunity in the pathogenesis of keratitis.
Hazlett LD
Ocul Immunol Inflamm; 2005; 13(2-3):133-8. PubMed ID: 16019672
[TBL] [Abstract][Full Text] [Related]
16. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey).
Joó I; Stanislavskii ES
J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):417-27. PubMed ID: 6819316
[TBL] [Abstract][Full Text] [Related]
17. Immunization against Pseudomonas aeruginosa. I. Induction of protection by an alcohol-precipitated fraction from the slime layer.
Alms TH; Bass JA
J Infect Dis; 1967 Jun; 117(3):249-56. PubMed ID: 4961397
[No Abstract] [Full Text] [Related]
18. Interactions of Pseudomonas aeruginosa proteases with the cells of the immune system.
Kharazmi A
Antibiot Chemother (1971); 1989; 42():42-9. PubMed ID: 2512845
[No Abstract] [Full Text] [Related]
19. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
[TBL] [Abstract][Full Text] [Related]
20. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
Cachia PJ; Hodges RS
Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
